| 1 |
Panda S, Tiwari A, Kumar V, Luthra K, Kumar K, Singh A. Protective Role of Vitamin D Against Development of Active Tuberculosis in Close Household Contacts of Pulmonary Tuberculosis Patients: A Prospective Cohort Study. Ind J Clin Biochem 2023. [DOI: 10.1007/s12291-022-01110-3] [Reference Citation Analysis]
|
| 2 |
Prinja S, Sharma A, Nadipally S, Rana SK, Bahuguna P, Rao N, Chakraborty G, Shankar M, Rai V. Impact and cost-effectiveness evaluation of nutritional supplementation and complementary interventions for tuberculosis treatment outcomes under mukti pay-for-performance model in Madhya Pradesh, India: A study protocol. Int J Mycobacteriol 2023;12:82-91. [PMID: 36926768 DOI: 10.4103/2212-5531.307071] [Reference Citation Analysis]
|
| 3 |
Tiwari D, Martineau AR. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies. Semin Immunol 2023;65:101672. [PMID: 36469987 DOI: 10.1016/j.smim.2022.101672] [Reference Citation Analysis]
|
| 4 |
Park HE, Lee W, Choi S, Jung M, Shin MK, Shin SJ. Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection. Front Immunol 2022;13:931876. [PMID: 36505429 DOI: 10.3389/fimmu.2022.931876] [Reference Citation Analysis]
|
| 5 |
Amalia F, Syamsunarno MRAA, Triatin RD, Fatimah SN, Chaidir L, Achmad TH. The Role of Amino Acids in Tuberculosis Infection: A Literature Review. Metabolites 2022;12:933. [PMID: 36295834 DOI: 10.3390/metabo12100933] [Reference Citation Analysis]
|
| 6 |
Cubillos-angulo JM, Nogueira BMF, Arriaga MB, Barreto-duarte B, Araújo-pereira M, Fernandes CD, Vinhaes CL, Villalva-serra K, Nunes VM, Miguez-pinto JP, Amaral EP, Andrade BB. Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs. Front Med 2022;9. [DOI: 10.3389/fmed.2022.970408] [Reference Citation Analysis]
|
| 7 |
Entrenas-Castillo M, Salinero-González L, Entrenas-Costa LM, Andújar-Espinosa R. Calcifediol for Use in Treatment of Respiratory Disease. Nutrients 2022;14:2447. [PMID: 35745177 DOI: 10.3390/nu14122447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Khoza LJ, Kumar P, Dube A, Demana PH, Choonara YE. Insights into Innovative Therapeutics for Drug-Resistant Tuberculosis: Host-Directed Therapy and Autophagy Inducing Modified Nanoparticles. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121893] [Reference Citation Analysis]
|
| 9 |
Kim YJ, Lee JY, Lee JJ, Jeon SM, Silwal P, Kim IS, Kim HJ, Park CR, Chung C, Han JE, Choi JW, Tak EJ, Yoo JH, Jeong SW, Kim DY, Ketphan W, Kim SY, Jhun BW, Whang J, Kim JM, Eoh H, Bae JW, Jo EK. Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection. Gut Microbes 2022;14:2073132. [PMID: 35579969 DOI: 10.1080/19490976.2022.2073132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Goyal JP, Singh S, Bishnoi R, Bhardwaj P, Kaur RJ, Dhingra S, Yadav D, Dutta S, Charan J. Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis. Expert Rev Anti Infect Ther 2022;:1-11. [PMID: 35477334 DOI: 10.1080/14787210.2022.2071702] [Reference Citation Analysis]
|
| 11 |
Cho H, Myung SK, Cho HE. Efficacy of Vitamin D Supplements in Treatment of Acute Respiratory Infection: A Meta-Analysis for Randomized Controlled Trials. Nutrients 2022;14:1144. [PMID: 35334804 DOI: 10.3390/nu14061144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Ganmaa D, Enkhmaa D, Nasantogtokh E, Sukhbaatar S, Tumur-Ochir KE, Manson JE. Vitamin D, respiratory infections, and chronic disease: Review of meta-analyses and randomized clinical trials. J Intern Med 2022;291:141-64. [PMID: 34537990 DOI: 10.1111/joim.13399] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 13 |
Pellegrini JM, Tateosian NL, Morelli MP, García VE. Shedding Light on Autophagy During Human Tuberculosis. A Long Way to Go. Front Cell Infect Microbiol 2021;11:820095. [PMID: 35071056 DOI: 10.3389/fcimb.2021.820095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Sinha P, Cegielski JP. Tuberculosis: nutritional management. Reference Module in Food Science 2022. [DOI: 10.1016/b978-0-12-821848-8.00093-7] [Reference Citation Analysis]
|
| 15 |
Kalra R, Tiwari D, Dkhar HK, Bhagyaraj E, Kumar R, Bhardwaj A, Gupta P. Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy. Int Rev Immunol 2023;42:43-70. [PMID: 34678117 DOI: 10.1080/08830185.2021.1990277] [Reference Citation Analysis]
|
| 16 |
Taha R, Abureesh S, Alghamdi S, Hassan RY, Cheikh MM, Bagabir RA, Almoallim H, Abdulkhaliq A. The Relationship Between Vitamin D and Infections Including COVID-19: Any Hopes? Int J Gen Med 2021;14:3849-70. [PMID: 34335050 DOI: 10.2147/IJGM.S317421] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Adikesavalu H, Gopalaswamy R, Kumar A, Ranganathan UD, Shanmugam S. Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium tuberculosis Infection. Medicina (Kaunas) 2021;57:522. [PMID: 34070995 DOI: 10.3390/medicina57060522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Kilinç G, Saris A, Ottenhoff THM, Haks MC. Host-directed therapy to combat mycobacterial infections. Immunol Rev 2021;301:62-83. [PMID: 33565103 DOI: 10.1111/imr.12951] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 19 |
Tunbridge M, França Gois PH. Vitamin D and the NLRP3 Inflammasome. Applied Sciences 2020;10:8462. [DOI: 10.3390/app10238462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 20 |
Hayford FEA, Dolman RC, Blaauw R, Nienaber A, Smuts CM, Malan L, Ricci C. The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis. Respir Res 2020;21:223. [PMID: 32847532 DOI: 10.1186/s12931-020-01488-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 21 |
Hackett EE, Sheedy FJ. An Army Marches on Its Stomach: Metabolic Intermediates as Antimicrobial Mediators in Mycobacterium tuberculosis Infection. Front Cell Infect Microbiol 2020;10:446. [PMID: 32984072 DOI: 10.3389/fcimb.2020.00446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Karbalaei M, Ghazvini K, Keikha M. Clinical efficacy of vitamin D supplementation on pulmonary TB patients: The evidence of clinical trials. J Clin Tuberc Other Mycobact Dis 2020;20:100174. [PMID: 32743080 DOI: 10.1016/j.jctube.2020.100174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Zhang J, Chen C, Yang J. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials. Chin Med J (Engl) 2019;132:2950-9. [PMID: 31833904 DOI: 10.1097/CM9.0000000000000554] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 24 |
Lin SY, Chiu YW, Yang HR, Chen TC, Hsieh MH, Wang WH, Chen YH. Association of vitamin D levels and risk of latent tuberculosis in the hemodialysis population. J Microbiol Immunol Infect 2021;54:680-6. [PMID: 32593557 DOI: 10.1016/j.jmii.2020.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 25 |
Ramalho R, Rao M, Zhang C, Agrati C, Ippolito G, Wang FS, Zumla A, Maeurer M. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. Semin Immunopathol 2020;42:279-313. [PMID: 32519148 DOI: 10.1007/s00281-020-00798-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 26 |
Rashid J, Kumar SS, Job KM, Liu X, Fike CD, Sherwin CMT. Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review. Paediatr Drugs 2020;22:279-93. [PMID: 32140997 DOI: 10.1007/s40272-020-00384-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 27 |
Young C, Walzl G, Du Plessis N. Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol 2020;13:190-204. [PMID: 31772320 DOI: 10.1038/s41385-019-0226-5] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 28 |
Büyükdere Y, Ayaz A. Tüberküloz ve D Vitamini Arasındaki İlişkinin Değerlendirilmesi: Güncel Yaklaşımlar. Sakarya Medical Journal 2019. [DOI: 10.31832/smj.549164] [Reference Citation Analysis]
|
| 29 |
Lavu EK, Johnson K, Banamu J, Pandey S, Carter R, Coulter C, Aia P, Majumdar SS, Marais BJ, Graham SM, Vince J. Drug-resistant tuberculosis diagnosis since Xpert® MTB/RIF introduction in Papua New Guinea, 2012-2017. Public Health Action 2019;9:S12-8. [PMID: 31579644 DOI: 10.5588/pha.19.0005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 30 |
Dara Y, Volcani D, Shah K, Shin K, Venketaraman V. Potentials of Host-Directed Therapies in Tuberculosis Management. J Clin Med 2019;8:E1166. [PMID: 31382631 DOI: 10.3390/jcm8081166] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 31 |
Teixeira HC, Dias LDS, Bizarro HDDS, Castro JMDA. Efeitos contrastantes da vitamina D sobre a resposta imune inata e adquirida e seu impacto na recuperação da tuberculose. HU Rev 2019;44:369-378. [DOI: 10.34019/1982-8047.2018.v44.22232] [Reference Citation Analysis]
|
| 32 |
Soeharto DA, Rifai DA, Marsudidjadja S, Roekman AE, Assegaf CK, Louisa M. Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report. Adv Prev Med 2019;2019:5181847. [PMID: 31321102 DOI: 10.1155/2019/5181847] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 33 |
Lestari T, Graham S, van den Boogard C, Triasih R, Poespoprodjo JR, Ubra RR, Kenangalem E, Mahendradhata Y, Anstey NM, Bailie RS, Ralph AP. Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study. Implement Sci 2019;14:31. [PMID: 30890160 DOI: 10.1186/s13012-019-0870-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 34 |
Bivona G, Agnello L, Lo Sasso B, Scazzone C, Butera D, Gambino CM, Iacolino G, Bellia C, Ciaccio M. Vitamin D in malaria: more hypotheses than clues. Heliyon 2019;5:e01183. [PMID: 30793054 DOI: 10.1016/j.heliyon.2019.e01183] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Jolliffe DA, Ganmaa D, Wejse C, Raqib R, Haq MA, Salahuddin N, Daley PK, Ralph AP, Ziegler TR, Martineau AR. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data. Eur Respir J 2019;53:1802003. [DOI: 10.1183/13993003.02003-2018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 36 |
Lange SM, McKell MC, Schmidt SM, Zhao J, Crowther RR, Green LC, Bricker RL, Arnett E, Köhler SE, Schlesinger LS, Setchell KDR, Qualls JE. l-Arginine Synthesis from l-Citrulline in Myeloid Cells Drives Host Defense against Mycobacteria In Vivo. J Immunol 2019;202:1747-54. [PMID: 30710047 DOI: 10.4049/jimmunol.1801569] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 37 |
Paik S, Kim JK, Chung C, Jo EK. Autophagy: A new strategy for host-directed therapy of tuberculosis. Virulence 2019;10:448-59. [PMID: 30322337 DOI: 10.1080/21505594.2018.1536598] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 38 |
Stek C, Allwood B, Walker NF, Wilkinson RJ, Lynen L, Meintjes G. The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy. Front Microbiol 2018;9:2603. [PMID: 30425706 DOI: 10.3389/fmicb.2018.02603] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 39 |
Bekele A, Gebreselassie N, Ashenafi S, Kassa E, Aseffa G, Amogne W, Getachew M, Aseffa A, Worku A, Raqib R, Agerberth B, Hammar U, Bergman P, Aderaye G, Andersson J, Brighenti S. Daily adjunctive therapy with vitamin D(3) and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia. J Intern Med 2018;284:292-306. [PMID: 29696707 DOI: 10.1111/joim.12767] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 40 |
Zhang Y, Zhu H, Yang X, Guo S, Liang Q, Lu Y, Chen X. Serum vitamin D level and vitamin D receptor genotypes may be associated with tuberculosis clinical characteristics: A case-control study. Medicine (Baltimore) 2018;97:e11732. [PMID: 30045341 DOI: 10.1097/MD.0000000000011732] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 41 |
Brighenti S, Bergman P, Martineau AR. Vitamin D and tuberculosis: where next? J Intern Med 2018. [PMID: 29804293 DOI: 10.1111/joim.12777] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 42 |
Wang J, Feng M, Ying S, Zhou J, Li X. Efficacy and Safety of Vitamin D Supplementation for Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Iran J Public Health 2018;47:466-72. [PMID: 29900130] [Reference Citation Analysis]
|
| 43 |
Ramos-Espinosa O, Islas-Weinstein L, Peralta-Álvarez MP, López-Torres MO, Hernández-Pando R. The use of immunotherapy for the treatment of tuberculosis. Expert Rev Respir Med 2018;12:427-40. [PMID: 29575946 DOI: 10.1080/17476348.2018.1457439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 44 |
Musteikienė G, Miliauskas S, Zaveckienė J, Žemaitis M, Vitkauskienė A. Factors associated with sputum culture conversion in patients with pulmonary tuberculosis. Medicina (Kaunas) 2017;53:386-93. [PMID: 29496377 DOI: 10.1016/j.medici.2018.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 45 |
Maceda EB, Gonçalves CCM, Andrews JR, Ko AI, Yeckel CW, Croda J. Serum vitamin D levels and risk of prevalent tuberculosis, incident tuberculosis and tuberculin skin test conversion among prisoners. Sci Rep 2018;8:997. [PMID: 29343733 DOI: 10.1038/s41598-018-19589-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 46 |
Ballif M, Zürcher K, Reid SE, Boulle A, Fox MP, Prozesky HW, Chimbetete C, Zwahlen M, Egger M, Fenner L; International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA). Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes. BMJ Open 2018;8:e017405. [PMID: 29330173 DOI: 10.1136/bmjopen-2017-017405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 47 |
Martineau AR, Jolliffe DA, Demaret J. Vitamin D and Tuberculosis. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809963-6.00103-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 48 |
Ganmaa D, Munkhzul B, Fawzi W, Spiegelman D, Willett WC, Bayasgalan P, Baasansuren E, Buyankhishig B, Oyun-Erdene S, Jolliffe DA, Xenakis T, Bromage S, Bloom BR, Martineau AR. High-Dose Vitamin D3 during Tuberculosis Treatment in Mongolia. A Randomized Controlled Trial. Am J Respir Crit Care Med 2017;196:628-37. [PMID: 28692301 DOI: 10.1164/rccm.201705-0936OC] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 49 |
Gois PHF, Ferreira D, Olenski S, Seguro AC. Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor? Nutrients 2017;9:E651. [PMID: 28672783 DOI: 10.3390/nu9070651] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 50 |
Harishankar M, Selvaraj P. Influence of Cdx2 and TaqI Gene Variants on Vitamin D3 Modulated Intracellular Chemokine Positive T-Cell Subsets in Pulmonary Tuberculosis. Clin Ther 2017;39:946-57. [PMID: 28476406 DOI: 10.1016/j.clinthera.2017.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 51 |
Ralph AP, Rashid Ali MRS, William T, Piera K, Parameswaran U, Bird E, Wilkes CS, Lee WK, Yeo TW, Anstey NM. Vitamin D and activated vitamin D in tuberculosis in equatorial Malaysia: a prospective clinical study. BMC Infect Dis 2017;17:312. [PMID: 28449659 DOI: 10.1186/s12879-017-2314-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 52 |
Ribeiro Vieira C, Laurides Ribeiro de Oliveira Lomeu F, de Castro Moreira ME, Stampini Duarte Martino H, Ribeiro Silva R. Clinical application of a cocoa and unripe banana flour beverage for overweight women with abdominal obesity: Prospective, double-blinded and randomized clinical trial: RIBEIRO VIEIRA et al. Journal of Food Biochemistry 2017;41:e12372. [DOI: 10.1111/jfbc.12372] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 53 |
Cegielski JP, Mcmurray DN, Soni T. Tuberculosis: Nutritional Management ☆. Reference Module in Biomedical Sciences 2017. [DOI: 10.1016/b978-0-12-801238-3.64096-5] [Reference Citation Analysis]
|
| 54 |
Ralph AP. l-Arginine in Pulmonary Tuberculosis. L-Arginine in Clinical Nutrition 2017. [DOI: 10.1007/978-3-319-26009-9_47] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 55 |
Si ZL, Kang LL, Shen XB, Zhou YZ. Adjuvant Efficacy of Nutrition Support During Pulmonary Tuberculosis Treating Course: Systematic Review and Meta-analysis. Chin Med J (Engl) 2015;128:3219-30. [PMID: 26612299 DOI: 10.4103/0366-6999.170255] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 56 |
Jenum S, Bakken R, Dhanasekaran S, Mukherjee A, Lodha R, Singh S, Singh V, Haks MC, Ottenhoff TH, Kabra SK, Doherty TM, Ritz C, Grewal HM. BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome. Sci Rep 2016;6:38841. [PMID: 27941850 DOI: 10.1038/srep38841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 57 |
Chesdachai S, Zughaier SM, Hao L, Kempker RR, Blumberg HM, Ziegler TR, Tangpricha V. The Effects of First-Line Anti-Tuberculosis Drugs on the Actions of Vitamin D in Human Macrophages. J Clin Transl Endocrinol 2016;6:23-9. [PMID: 28111615 DOI: 10.1016/j.jcte.2016.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 58 |
Wallis RS, Zumla A. Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review. Open Forum Infect Dis 2016;3:ofw151. [PMID: 27800526 DOI: 10.1093/ofid/ofw151] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 59 |
Arnedo-pena A, Juan-cerdan JV, Romeu-garcia MA, Garcia-ferrer D, Iborra-millet J, Ferrero-vega JA, Bellido-blasco JB, Meseguer-ferrer N, Pardo-serrano F. Tuberculosis and Vitamin D Status Among the Contacts of Pulmonary Tuberculosis Patients. Avicenna J Clin Microbiol Infect 2016;4:36889-36889. [DOI: 10.17795/ajcmi-36889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 60 |
Grobler L, Nagpal S, Sudarsanam TD, Sinclair D. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2016;:CD006086. [PMID: 27355911 DOI: 10.1002/14651858.CD006086.pub4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 61 |
Harishankar M, Selvaraj P. Regulatory role of Cdx-2 and Taq I polymorphism of vitamin D receptor gene on chemokine expression in pulmonary tuberculosis. Human Immunology 2016;77:498-505. [DOI: 10.1016/j.humimm.2016.04.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 62 |
Honarvar MR, Eghtesadi S, Gill P, Jazayeri S, Vakili MA, Shamsardekani MR, Abbasi A. The effect of green tea extract supplementation on sputum smear conversion and weight changes in pulmonary TB patients: A randomized controlled trial. Med J Islam Repub Iran 2016;30:381. [PMID: 27493925] [Reference Citation Analysis]
|
| 63 |
Sloan DJ, Mwandumba HC, Kamdolozi M, Shani D, Chisale B, Dutton J, Khoo SH, Allain TJ, Davies GR. Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes. Int J Tuberc Lung Dis 2015;19:904-11. [PMID: 26162355 DOI: 10.5588/ijtld.15.0071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 64 |
Zittermann A, Pilz S, Hoffmann H, März W. Vitamin D and airway infections: a European perspective. Eur J Med Res 2016;21:14. [PMID: 27009076 DOI: 10.1186/s40001-016-0208-y] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 65 |
Reeme AE, Robinson RT. Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage Tuberculosis in C3HeB/FeJ Mice. J Immunol 2016;196:1293-304. [PMID: 26729807 DOI: 10.4049/jimmunol.1500931] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 66 |
Nouari W, Ysmail-Dahlouk L, Aribi M. Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa. Int Immunopharmacol 2016;30:94-101. [PMID: 26655879 DOI: 10.1016/j.intimp.2015.11.033] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 67 |
Lakio S, Morton DA, Ralph AP, Lambert P. Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery. Asian Journal of Pharmaceutical Sciences 2015;10:528-40. [DOI: 10.1016/j.ajps.2015.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 68 |
Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Kempker RR, Frediani JK, Mirtskhulava V, Alvarez JA, Lomtadze N, Vashakidze L, Hao L, Del Rio C, Tangpricha V, Blumberg HM, Ziegler TR. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial. Am J Clin Nutr 2015;102:1059-69. [PMID: 26399865 DOI: 10.3945/ajcn.115.113886] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 69 |
Yasueda A, Urushima H, Ito T. Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review. Integr Cancer Ther 2016;15:17-39. [PMID: 26503419 DOI: 10.1177/1534735415610427] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 70 |
Mily A, Rekha RS, Kamal SM, Arifuzzaman AS, Rahim Z, Khan L, Haq MA, Zaman K, Bergman P, Brighenti S, Gudmundsson GH, Agerberth B, Raqib R. Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial. PLoS One 2015;10:e0138340. [PMID: 26394045 DOI: 10.1371/journal.pone.0138340] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 71 |
Rapovy SM, Zhao J, Bricker RL, Schmidt SM, Setchell KD, Qualls JE. Differential Requirements for L-Citrulline and L-Arginine during Antimycobacterial Macrophage Activity. J Immunol 2015;195:3293-300. [PMID: 26311904 DOI: 10.4049/jimmunol.1500800] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 72 |
Junaid K, Rehman A, Saeed T, Jolliffe DA, Wood K, Martineau AR. Genotype-independent association between profound vitamin D deficiency and delayed sputum smear conversion in pulmonary tuberculosis. BMC Infect Dis 2015;15:275. [PMID: 26193879 DOI: 10.1186/s12879-015-1018-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 73 |
Facchini L, Venturini E, Galli L, Martino MD, Chiappini E. Vitamin D and tuberculosis: a review on a hot topic. Journal of Chemotherapy 2015;27:128-38. [DOI: 10.1179/1973947815y.0000000043] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 74 |
Kearns MD, Alvarez JA, Seidel N, Tangpricha V. Impact of vitamin D on infectious disease. Am J Med Sci 2015;349:245-62. [PMID: 25334038 DOI: 10.1097/MAJ.0000000000000360] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 75 |
Cegielski P, Vernon A. Tuberculosis and vitamin D: what's the rest of the story? Lancet Infect Dis 2015;15:489-90. [PMID: 25863560 DOI: 10.1016/S1473-3099(15)70163-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 76 |
Daley P, Jagannathan V, John KR, Sarojini J, Latha A, Vieth R, Suzana S, Jeyaseelan L, Christopher DJ, Smieja M. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15:528-534. [PMID: 25863562 DOI: 10.1016/s1473-3099(15)70053-8] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 77 |
Wallis RS, Hafner R. Advancing host-directed therapy for tuberculosis. Nat Rev Immunol 2015;15:255-63. [PMID: 25765201 DOI: 10.1038/nri3813] [Cited by in Crossref: 211] [Cited by in F6Publishing: 215] [Article Influence: 26.4] [Reference Citation Analysis]
|
| 78 |
Farazi A, Shafaat O, Sofian M, Kahbazi M. Arginine adjunctive therapy in active tuberculosis. Tuberc Res Treat 2015;2015:205016. [PMID: 25734013 DOI: 10.1155/2015/205016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 79 |
William T, Parameswaran U, Lee WK, Yeo TW, Anstey NM, Ralph AP. Pulmonary tuberculosis in outpatients in Sabah, Malaysia: advanced disease but low incidence of HIV co-infection. BMC Infect Dis 2015;15:32. [PMID: 25636334 DOI: 10.1186/s12879-015-0758-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 80 |
Lucas RM, Norval M, Neale RE, Young AR, de Gruijl FR, Takizawa Y, van der Leun JC. The consequences for human health of stratospheric ozone depletion in association with other environmental factors. Photochem Photobiol Sci 2015;14:53-87. [DOI: 10.1039/c4pp90033b] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 81 |
Lodha R, Mukherjee A, Singh V, Singh S, Friis H, Faurholt-Jepsen D, Bhatnagar S, Saini S, Kabra SK, Grewal HM; Delhi Pediatric TB Study Group. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. Am J Clin Nutr 2014;100:1287-97. [PMID: 25332327 DOI: 10.3945/ajcn.113.082255] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 82 |
Arnedo-Pena A, Juan-Cerdán JV, Romeu-García MA, García-Ferrer D, Holguín-Gómez R, Iborra-Millet J, Pardo-Serrano F. Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study. Epidemiol Infect 2015;143:1731-41. [PMID: 25274036 DOI: 10.1017/S0950268814002386] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 83 |
Kearns MD, Tangpricha V. The role of vitamin D in tuberculosis. J Clin Transl Endocrinol 2014;1:167-9. [PMID: 29159097 DOI: 10.1016/j.jcte.2014.08.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 84 |
Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire GP, Kelly PM, Anstey NM. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One 2013;8:e80302. [PMID: 24312209 DOI: 10.1371/journal.pone.0080302] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 85 |
Ralph AP, Lucas RM. Vitamin D and tuberculosis: hope or hype? Medical Journal of Australia 2013;199:648-9. [DOI: 10.5694/mja13.11174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 86 |
Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire G, Kelly PM, Anstey NM, Ralph AP. Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups. PLoS One 2013;8:e76077. [PMID: 24086690 DOI: 10.1371/journal.pone.0076077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 87 |
Ralph AP, Yeo TW, Salome CM, Waramori G, Pontororing GJ, Kenangalem E, Sandjaja, Tjitra E, Lumb R, Maguire GP, Price RN, Chatfield MD, Kelly PM, Anstey NM. Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment. J Infect Dis 2013;208:616-26. [PMID: 23737604 DOI: 10.1093/infdis/jit248] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
